Abstract:When people around him yawn, he yawns. When the chatroom he is in starts discussing brownies, biscuits and chocolate-covered strawberries he finds himself salivating. He has perfect trust in authority. He is easily persuaded and always abides by authority's advice. These are all indications that he is very suggestible indeed. It is not difficult to distinguish between these individuals and those who are less suggestible. Those who are more easily impressionable include preschool children, women in weak health and persons with somatization disorders. We have noticed that many psychological, social and behavioural factors tend to influence the efficacy of medication and the overall therapeutic outcome for these individuals compared with those who are less suggestible. Over the last two decades little attention has been paid to two psychosocial dimensions of pharmacology. The first dimension includes the psychological response of patients and families to medications and pharmacotherapy. Individuals in modern countries may accept medications with unwavering belief in their effectiveness, whereas some ethnic groups do not. The second dimension that has been largely overlooked is the psychological, social and behavioural factors that influence drug metabolism, efficacy and side-effects. In order to describe the phenomenon as well as to differentiate it from psychopharmacology, we here coin a new term: psychosocialpharmacology[1]. Psychopharmacology studies drug-induced changes in mood, sensation, thinking and behaviour [2]. Psychosocialpharmacology is a new interdisciplinary approach that includes psychology, sociology and clinical pharmacology. It explores the puzzling efficacy differences associated with nonpharmacological factors among patients. It advocates considering the patient's psychological, social and behavioural components that influence drug efficacy in a similar manner as does the patient's genetics and physiology, and the disease itself. Furthermore, psychosocialpharmacology also studies the effect of the medical professional's manner and speech on medication efficacy. As a new element of pharmacology, we think that psychosocialpharmacology demands to answer the following questions: Since many major diseases from cancer to AIDS are involved with various affective disorders, in what manner and to what extent do mood disorders or personality types affect drug efficacy [3]? Are there differences in drug efficacy among individuals with dominant, compliant, introverted or extroverted personalities? It is well known that a good medical professional–patient relationship can be used to improve therapy, even in largely unknown, nonspecific and unpredictable ways. The generalized comfort and emotional support mechanisms are beneficial to patients [4, 5]. However, why does an empathic, physically attractive, likeable and competent medical professional contribute a positive pharmacotherapeutic outcome and, furthermore, how does it happen? What is the underlying hidden mechanism at work here? Most people in a developing country look favourably upon medicine from Western, developed countries. They have higher expectations of imported medicine and, whenever possible, they prefer it to homemade remedies. Is there any evidence to support the reasoning behind these beliefs? Informed consent refers to the permission given by a person prior to surgery or other types of medical treatment. The patient must understand the potential risks and benefits of the treatment and must legally agree to accept these inherent risks in writing. Obviously, the subtext of information provided by the medical professional inevitably contains suggestion. The question is: are we providing patients with information that is clinically helpful or harmful? More specifically, when providing information to individuals who are especially suggestible, does the medical professional use the power of positive suggestion to attain beneficial pharmacotherapeutic outcomes [6]? Many individuals around the world follow spiritual traditions. Spiritual complementary therapies are frequently used in both developed and developing countries. Do these social and cultural behaviours – religious rituals (such as prayer and exorcism), incantation, purgation, and cleansing of the mind by talking out the evil – augment the effects of medications? In summary, psychosocial factors have always played an important role in treating patients with medications, and we cannot overemphasize the importance of paying attention to these factors. It is because of this that we propose the term psychosocialpharmacology to arouse great care in the clinical pharmacology world. We expect that individuals of deep insight will take this issue into consideration.

Child psychopharmacology: Is it more similar than different from adult psychopharmacology?

New Horizons in Pediatric Psychopharmacology

Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I

Several Concerns Arise when the Results Are Interpreted

Ethical considerations in clinical training, care and research in psychopharmacology

Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II

Common practical questions - and answers - at the British Association for Psychopharmacology child and adolescent psychopharmacology course

Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications

Treatment of psychiatric disorders in children and adolescents

The Future of Child and Adolescent Clinical Psychopharmacology: A Systematic Review of Phase 2, 3, or 4 Randomized Controlled Trials of Pharmacologic Agents Without Regulatory Approval or for Unapproved Indications

Recent international trends in psychotropic medication prescriptions for children and adolescents

Pharmacogenomics in Psychiatry: An Asian Perspective

How can we better address the pharmacokinetics of antipsychotics in children and adolescents?

A History of Child and Adolescent Treatment Through a Distillation Lens: Looking Back to Move Forward

Drug Therapy for Children in China.

Psychotropic drug prescribing in child and adolescent learning disability psychiatry

Psychological, Social and Behavioural Factors That Influence Drug Efficacy: a Noteworthy Research Subject in Clinical Pharmacology

Pharmacotherapy of early-onset depression. Update and new directions

Sustainable child and adolescent psychiatry

Learning the "Science of the Art of Prescribing": From Evidence-based Algorithms to Individualized Medicine in Psychiatric Care

World Psychiatric Association-Asian Journal of Psychiatry Commission on Psychiatric Education in the 21st century